Hutch News
Results per Page:
New trial aims to curb HPV-related cancers in HIV+ women and children
International ‘dream team’ to use new technologies and prevention approaches to help those at highest risk
Sabes study fuels comprehensive HIV research
From the Duerr lab, Vaccine and Infectious Disease Division, and collaborators
STEP analysis confirms higher HIV risk in some vaccine participants
Ann Duerr follow-up study of experimental HIV vaccine verifies certain subgroups had increased risk of becoming infected after vaccination; risk decreased over time
A visionary in the fight to prevent AIDS
Doctor, scientist, HIV-infection expert, Ann Duerr's international experiences fuel her commitment to pursue a vaccine